Join us at the International Society of Liquid Biopsy 6th Annual Congress (ISLB 2024)

Accelerating the future of liquid biopsy

Thermo Fisher Scientific is proud to partner with the International Society of Liquid Biopsy (ISLB) for the 6th Annual Congress in Denver, CO, USA.

As the world leader in serving science, Thermo Fisher Scientific enables our customers to accelerate the future of liquid biopsies using our comprehensive sample purification, digital PCR (dPCR), and next-generation sequencing (NGS) solutions.

We offer complete liquid biopsy workflow solutions from sample preparation through data analysis and interpretation.

Learn more about our sample preparation kits and NGS-based liquid biopsy solutions at Booth #205

> Explore More

Industry Symposium

Liquid Biopsy, Quo Vadis? Real-World Clinical Case Examples in 2024 and Future Applications in Oncology*

Date: Sunday, November 24th, 2024 | 4:30-5:30pm MST

Location: Adams Ballroom B

This symposium is set to offer an engaging and informative session for clinicians, researchers, and industry professionals. By featuring real-world cases and fostering dynamic discussions, it will serve as a platform for exchanging valuable knowledge and driving forward the conversation on the future of liquid biopsy in oncology. 

Each panelist will present their unique cases, showcasing how liquid biopsy has been effectively used in their respective clinical practices. The format is designed to promote interaction not only between the panelists but also with the audience. The emphasis will be on creating a lively dialogue, where panelists will share their insights, discuss challenges, and compare perspectives on how liquid biopsy is shaping the future of oncology. 

> Add reminder to your calendar

Speakers

Dr. Luca Quagliata, PhD, MCMAS, COA
Thermo Fisher Scientific
Milano, Italy

Dr. Nicola Fusco, MD
European Institute of Oncology IRCC,
Milano, Italy

Featured Solutions at ISLB 2024

KingFisher Automated Purification Systems

MagMAX kits for Cell-Free NA isolation

Ion Torrent Genexus NGS System 

Oncomine Cell-Free Assays for Liquid Biopsy Research 

Interested in more information on liquid biopsy solutions from Thermo Fisher Scientific? 

Explore the Genexus

One complete NGS system

The Ion Torrent™ Genexus™ System is a turnkey next-generation sequencing (NGS) solution that automates the end-to-end workflow from the biological specimen all the way to the final report and delivers results in as little as 24 hours.*

Thinking about how the Genexus System works and how it could fit into your lab?

In our virtual laboratory environment powered by augmented reality (AR) technology, you can see:

• How the Ion Torrent™ Genexus™ Integrated Sequencer and Genexus™ Purification System fit into your space
• Each step of the NGS workflow, including purification, sequencing, and analysis
• Sample types and applications supported by the Genexus System

Additional Resources

For Research Use Only.  Not for use in diagnostic procedures.

*This presentation was approved by the Scientific
Program Committee as an independent activity held in conjunction with the 6th Annual Congress of Liquid Biopsy (ISLB 2024). This
presentation is not sponsored or endorsed by ISLB 2024.

Case Number: 58040 1124